Companies: 10,795·Total market cap: $144.5T
OptimizeRx Corporation

OptimizeRx Corporation

OPRXNASDAQHealthcare● Active
$5.05
$-0.06(-1.17%)
Market Cap$94763629
P/E Ratio
52W High$22.25
52W Low$4.57
Overview

OptimizeRx Corporation (OPRX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

oprx · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 15 Wall Street analysts in the past 3 months

SellBuy

Buy

15 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
11
Hold
4
Sell
0
Strong Sell
0
Total: 15 · Buy rate: 73.3%

12-Month Price Target

High

$14.00

Consensus

$10.50

+107.9% upside

Low

$7.00

Median: $10.5 · Last Close: $5.05

The OptimizeRx Corporation (OPRX) analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month OPRX price target is $10.50, representing +107.9% upside from the current price of $5.05.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $11 (107.9%)

Consensus Target

$10.50

107.9% upside

High Target

$14

177.2%

Low Target

$7

38.6%

Current Price

$5.05

as of today

Based on analyst price targets, the OPRX stock price prediction for the next 12 months ranges from $7 to $14. The consensus OPRX price forecast of $10.50 implies 107.9% upside from the current price of $5.05.

Short-Term Price Prediction

Low Activity

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$5.030.39%

1-day model range: $4.9–$5.16. Peak: $5.16 (-0.39%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027-50.0%
2028-62.5%
2029-67.2%
2030-69.2%
2031-70.2%
Confidence:Very Low
⚠️ 2027 projections carry Very Low confidence. Treat as directional guidance only.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

🚫

Insufficient Trading Activity — Sentiment Signals Disabled

This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.

RSI (14)49.1
MACDBEARISH

Moving Averages · OPRX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$5.15SELL
MA 10$5.12SELL
MA 20$5.19SELL
MA 50$5.99SELL
MA 100$7.40SELL
MA 200$12.00SELL
Current $OPRX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.13SELL
EMA 10$5.16SELL
EMA 20$5.33SELL
EMA 50$6.07SELL
EMA 100$7.63SELL
EMA 200$9.53SELL
Current $OPRX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Stephens & Co.2026-05-13
Maintains
Equal WeightEqual Weight
Stifel2026-05-13
Maintains
BuyBuy
Lake Street2026-05-13
Maintains
BuyBuy
B. Riley Securities2026-05-13
Maintains
BuyBuy
Lake Street2026-03-06
Maintains
BuyBuy
Stifel2026-03-06
Maintains
BuyBuy
Roth Capital2026-03-06
Maintains
BuyBuy
Stephens & Co.2026-03-06
Maintains
Equal WeightEqual Weight
B. Riley Securities2026-03-06
Maintains
BuyBuy
Stephens & Co.2025-11-17
Maintains
Equal WeightEqual Weight

Wall Street analysts have recently issued updated ratings on OptimizeRx Corporation (OPRX) stock. Of the recent 68 rating actions, 0 were upgrades and 1 were downgrades. 15 analysts currently cover OPRX.

Analyst Recommendation Trends

Buy ratings13↑ +2
Hold ratings01↑ +1
Sell ratings00

OPRX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$83M

↓ 23.0% YoY

Revenue Next Year

$90M

↑ 8.4% YoY

EPS This Year

$-1.01

EPS Next Year

$0.31

↓ 130.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast OPRX EPS of $-1.01 for the current fiscal year, based on estimates from 4 analysts. The OPRX revenue forecast is $83M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The OPRX stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OPRX price target is $10.50 (+107.9% upside), with an analyst consensus of Buy.

The OPRX short-term stock prediction for tomorrow is $5.03 (-0.39%). The OPRX stock prediction for 2030 projects a range of $1–$2.

OptimizeRx Corporation trades on NASDAQ under the ticker OPRX. The OPRX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 73% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

OPRX forecast · 8 questions

According to 15 Wall Street analysts, the average 12-month OPRX price target is $10.50, with a high forecast of $14.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +107.9% potential upside from the current price of $5.05.

OPRX price targetWhat is OPRX price targetOPRX analyst price targetOPRX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.